share_log

康希諾生物:股份發行人的證券變動月報表

CANSINOBIO: Monthly Return of Equity Issuer on Movements in Securities

香港交易所 ·  Apr 2 23:15
Summary by Moomoo AI
康希諾生物股份公司於2024年4月3日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年3月31日的公司股份變動情況。報告顯示,康希諾生物的H股(股份代號06185)和A股(股份代號688185)在過去一個月內均無增減,H股和A股的結存數量分別維持在132,670,900股和114,778,999股。此外,公司確認在2024年3月期間沒有進行A股的回購活動。康希諾生物於2022年1月23日董事會通過的員工持股計劃或股權激勵計劃下的A股回購方案,自2022年2月7日至2022年12月1日期間回購的406,098股A股至今未注銷,並且在特定情況下才可能進行注銷。
康希諾生物股份公司於2024年4月3日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年3月31日的公司股份變動情況。報告顯示,康希諾生物的H股(股份代號06185)和A股(股份代號688185)在過去一個月內均無增減,H股和A股的結存數量分別維持在132,670,900股和114,778,999股。此外,公司確認在2024年3月期間沒有進行A股的回購活動。康希諾生物於2022年1月23日董事會通過的員工持股計劃或股權激勵計劃下的A股回購方案,自2022年2月7日至2022年12月1日期間回購的406,098股A股至今未注銷,並且在特定情況下才可能進行注銷。
Consino Biological Corporation filed with Hong Kong Trading and Settlement Limited on 3 April 2024 with Hong Kong Trading and Settlement Limited on 3 April 2024, reporting the changes in the company's shares for the year ended 31 March 2024. The report showed that Conchino Bios's H shares (stock code 06185) and A shares (stock code 688185) were unchanged over the past month, and the number of H shares and A shares held at 132,670,900 shares and 114,778,999 shares, respectively. In addition, the company confirmed that there was no repurchase of A shares during March 2024. Consino Bio's A share repurchase plan under the Employee Share Plan or Equity Incentive Scheme approved by the Board of Directors on January 23, 2022, 406,098 shares of A shares repurchased between February 7, 2022 and December 1, 2022, have not been repurchased until now and may only be repurchased under certain circumstances.
Consino Biological Corporation filed with Hong Kong Trading and Settlement Limited on 3 April 2024 with Hong Kong Trading and Settlement Limited on 3 April 2024, reporting the changes in the company's shares for the year ended 31 March 2024. The report showed that Conchino Bios's H shares (stock code 06185) and A shares (stock code 688185) were unchanged over the past month, and the number of H shares and A shares held at 132,670,900 shares and 114,778,999 shares, respectively. In addition, the company confirmed that there was no repurchase of A shares during March 2024. Consino Bio's A share repurchase plan under the Employee Share Plan or Equity Incentive Scheme approved by the Board of Directors on January 23, 2022, 406,098 shares of A shares repurchased between February 7, 2022 and December 1, 2022, have not been repurchased until now and may only be repurchased under certain circumstances.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more